Duopharma Biotech

Duopharma Biotech Berhad, a Malaysian Pharmaceutical Preparation Manufacturing company, reported its Scope 1 and 2 emissions for 2024 as 1,839,000 kg CO2e. For 2023, their Scope 1 and 2 emissions were also 1,839,000 kg CO2e. In 2022, Duopharma Biotech reported Scope 1 emissions of 1,287,990 kg CO2e, Scope 2 emissions of 38,062,900 kg CO2e, and Scope 3 emissions of 672,600 kg CO2e. In 2021, their Scope 1 emissions were 1,060,460 kg CO2e, Scope 2 emissions were 32,539,400 kg CO2e, and Scope 3 emissions were 2,255,900 kg CO2e. For 2020, Scope 1 emissions were 1,141,320 kg CO2e and Scope 2 emissions were 21,006,800 kg CO2e. In 2019, Scope 1 emissions were 1,115,210 kg CO2e and Scope 2 emissions were 23,063,600 kg CO2e. The company has also disclosed a Greenhouse Gas (“GHG”) Scope 3 emissions baseline of 6.0 per count in 2024. No specific carbon reduction targets or commitments were provided in the available data.